SUMO $12.04 -0.083%
NXPL $2.68 -4.2857%
CBRE $72.74 -1.2222%
TACO $12.51 0%
SGMO $1.32 1.5385%
ADT $5.93 -1.6584%
0OHK.L $282.50 1.8018%
WILC $13.41 -1.9459%
TREC $0.00 0%
EXK $3.40 -1.4493%
VRCI.L $13.75 -5.1724%
OIT.L $166.00 0.3021%
XBGG.L $6 889.00 0.2182%
HSM.L $450.00 0%
8059.HK $0.02 0%
TAVI.L $7.75 0%
IFGL $20.78 -1.1888%
BCV $16.14 -0.4318%
SBIO $31.65 -0.9026%
PGW.NZ $4.30 -1.1494%
TMBR $1.56 -2.5%
0P0001IU24.L $10 231.40 0.2283%
1845.HK $0.26 0%
2825.HK $23.82 4.84155%
FTAI-PC $25.72 0%
SPX5.L $330.60 0.3552%
LNA.PA $30.85 -2.0635%
RHCB $45.43 0%
REFR $1.55 0.6494%
HAWX $27.77 -0.1079%
ASPC $6.95 0%
EEMU.PA $13.00 0.6193%
TEN $19.99 0%
ENV $55.97 -0.0536%
NGL-PB $23.03 -3.2353%
HOOD $8.83 -8.5492%
GRPN $3.23 -3.1532%
CPG.L $2 157.00 2.0341%
0267.HK $10.00 -1.7682%
PLUS.L $1 519.00 -0.1315%
MMSB $24.04 0%
BYNOU $10.47 -0.6641%
GLOP-PB $22.20 -0.942%
EQNR $27.80 0.1802%
MGK $208.99 -0.9244%
3BSR.L $156.30 4.5135%
LVAC $10.44 0.24%
VTEX $3.89 0%
NKTX $4.50 0.5593%
ENGI4.SA $7.85 -2.4845%
LUXU.PA $227.84 -1.0778%
PYCR $21.48 1.8975%
HBNC $7.78 0.3871%
SSFI $21.91 0.2976%
SDX.L $4.30 -5.4945%
STRCW $0.10 -6.5421%
HYGN.L $9.34 1.4389%
ENPC $9.25 0%
JFEN3.SA $2.37 -1.25%
IDIV $6.96 0%
MWET3.SA $29.98 0%
SRWG.L $1 207.80 -0.3136%
EMAE4.SA $62.00 1.3237%
FLLV $46.82 -0.4677%
RDW.L $528.00 2.924%
HOMZ $35.55 -0.1124%
8159.HK $0.18 -1.0989%
ALROC.PA $2.72 -5.8824%
RELY $18.22 0.7186%
ACCB.BR $0.03 0.6711%
NAC $10.77 -0.2687%
DLO $13.74 0.7331%
BGEU.L $94.00 0.4274%
KSICU $10.13 0%
1899.HK $1.64 0%
IHI $55.33 -0.4856%
MANU $18.03 -1.8508%
DPG $12.43 -0.0008%
0S10.L $4.83 1.5268%
LOVE $24.97 -2.7085%
UG $9.49 1.9334%
FJPR.L $4.92 0.9806%
1983.HK $2.81 1.0791%
CRL $190.83 -2.516%
2108.HK $0.23 21.164%
VGR $11.07 -0.9839%
MRK $116.82 -0.621%
HACK $45.46 -0.9911%
MIY $11.01 -0.4116%
BCOW $6.49 0.6202%
BXSL $25.39 -0.4357%
2314.HK $2.97 -2.6229%
CVA $20.26 0%
ADXN $0.90 1.2261%
BSE.L $9.45 -5.5%
0029.HK $12.42 6.518%
0841.HK $0.26 0%
OREGE.PA $0.27 0.3704%
QNCX $1.54 -6.6667%
0NL1.L $18.43 -1.7409%
Eng
Логотип
Eng
Лого

Photocure ASA 0IMT.L

$52.50

+$1.23 (2.34%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    10871810.00000000

  • week52high

    115.20

  • week52low

    51.20

  • Revenue

  • P/E TTM

    0

  • Beta

    0.83473200

  • EPS

    -2.53000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    07 мая 2023 г. в 04:52

Описание компании

Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек